Feb 14 (Reuters) - Lavipharm SA LPHr.AT :
* LAVIPHARM ANNOUNCES THE CESSATION OF GROUP’S
PHARMACEUTICAL
WHOLESALE ACTIVITIES AND LOGISTICS SERVICES TO THIRD PARTIES
(3PL) AND THE TRANSFER OF CERTAIN ASSETS OF ITS SUBSIDIARY LAS
TO PROFARM
* MOST OF THE EMPLOYEES WILL BE EMPLOYED BY PROFARM OR
TRANSFERRED
TO THE CORE ACTIVITIES OF THE LAVIPHARM GROUP
* DISCONTINUED ACTIVITY'S CONTRIBUTION TO SALES FOR THE
YEARS 2023
TO 2026 WOULD HAVE DECREASED CONTINUOUSLY DUE TO THE STRONG
GROWTH OF THE GROUP’S CORE ACTIVITIES
* TOTAL PROFIT BEFORE TAX FROM THE CESSATION IS ESTIMATED AT
EUR
0.4 MILLION WHICH WILL BE RECOGNISED IN THE FINANCIAL RESULTS OF
Q1 2024
Further company coverage: LPHr.AT
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))